Teladoc Stock Filter Stocks by Fundamentals
| TDOC Stock | USD 13.30 0.32 2.47% |
Teladoc fundamentals help investors to digest information that contributes to Teladoc's financial success or failures. It also enables traders to predict the movement of Teladoc Stock. The fundamental analysis module provides a way to measure Teladoc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Teladoc stock.
Teladoc | Shares Owned by Institutions |
Teladoc Current Valuation Drivers
We derive many important indicators used in calculating different scores of Teladoc from analyzing Teladoc's financial statements. These drivers represent accounts that assess Teladoc's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Teladoc's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 6.0B | 18.1B | 14.4B | 3.8B | 3.5B | 5.7B | |
| Enterprise Value | 6.0B | 18.8B | 14.8B | 4.5B | 4.0B | 5.9B |
Teladoc Institutional Holders
Institutional Holdings refers to the ownership stake in Teladoc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Teladoc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Teladoc's value.| Shares | Millennium Management Llc | 2023-12-31 | 2.2 M | Man Group Plc | 2023-12-31 | 2 M | Susquehanna International Group, Llp | 2023-12-31 | 1.7 M | Charles Schwab Investment Management Inc | 2023-12-31 | 1.7 M | Baillie Gifford & Co Limited. | 2023-12-31 | 1.6 M | Credit Suisse First Boston (csfb) | 2023-12-31 | 1.3 M | Himension Fund | 2023-12-31 | 1.1 M | Bnp Paribas Arbitrage, Sa | 2023-12-31 | 923.7 K | Bank Of New York Mellon Corp | 2023-12-31 | 859.5 K | Ark Investment Management Llc | 2023-12-31 | 21.2 M | Vanguard Group Inc | 2023-12-31 | 17.5 M |
Teladoc Fundamentals
| Return On Equity | -0.0951 | ||||
| Return On Asset | -0.0301 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | (0.05) % | ||||
| Current Valuation | 2.64 B | ||||
| Shares Outstanding | 169.31 M | ||||
| Shares Owned By Insiders | 0.76 % | ||||
| Shares Owned By Institutions | 71.64 % | ||||
| Number Of Shares Shorted | 20.88 M | ||||
| Price To Earning | (21.84) X | ||||
| Price To Book | 1.03 X | ||||
| Price To Sales | 0.92 X | ||||
| Revenue | 2.6 B | ||||
| Gross Profit | 1.66 B | ||||
| EBITDA | 192.05 M | ||||
| Net Income | (220.37 M) | ||||
| Cash And Equivalents | 883.7 M | ||||
| Cash Per Share | 5.47 X | ||||
| Total Debt | 1.59 B | ||||
| Debt To Equity | 0.26 % | ||||
| Current Ratio | 3.38 X | ||||
| Book Value Per Share | 13.96 X | ||||
| Cash Flow From Operations | 350.02 M | ||||
| Short Ratio | 5.01 X | ||||
| Earnings Per Share | (1.34) X | ||||
| Price To Earnings To Growth | (1.01) X | ||||
| Target Price | 19.7 | ||||
| Number Of Employees | 4.82 K | ||||
| Beta | 0.94 | ||||
| Market Capitalization | 2.2 B | ||||
| Total Asset | 4.39 B | ||||
| Retained Earnings | (15.23 B) | ||||
| Working Capital | 1.07 B | ||||
| Current Asset | 151.58 M | ||||
| Current Liabilities | 17.99 M | ||||
| Net Asset | 4.39 B |
About Teladoc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Teladoc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Teladoc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Teladoc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Teladoc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teladoc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teladoc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teladoc Stock:Check out Teladoc Piotroski F Score and Teladoc Altman Z Score analysis. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Teladoc Stock analysis
When running Teladoc's price analysis, check to measure Teladoc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teladoc is operating at the current time. Most of Teladoc's value examination focuses on studying past and present price action to predict the probability of Teladoc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teladoc's price. Additionally, you may evaluate how the addition of Teladoc to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is Teladoc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teladoc. If investors know Teladoc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teladoc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.34) | Revenue Per Share 15.813 | Quarterly Revenue Growth 0.036 | Return On Assets (0.03) | Return On Equity (0.1) |
The market value of Teladoc is measured differently than its book value, which is the value of Teladoc that is recorded on the company's balance sheet. Investors also form their own opinion of Teladoc's value that differs from its market value or its book value, called intrinsic value, which is Teladoc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teladoc's market value can be influenced by many factors that don't directly affect Teladoc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teladoc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teladoc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.